Keros Therapeutics Inc (KROS)

Keros Therapeutics Inc (KROS) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	1,687% 0.143	0.008	-	-	-
Operating Expenses	7.65% 46.60	43.29	41.34	38.87	31.96
Benefits Costs and Expenses	153.14	-	-	-	-
Costs And Expenses	31.51% 29.65	43.29	-	-	-
Operating Income/Loss	7.34% -46.45	-43.28	-41.34	-38.87	-31.96
Nonoperating Income/Loss	61.77% 6.212	3.84	3.832	3.065	2.242
Income/Loss From Continuing Operations Before Tax	1.91M% -153.00	0.008	-37.51	-35.80	-29.72
Income/Loss From Continuing Operations After Tax	2.04% -40.24	-39.44	-37.51	-35.80	-29.72
Net Income/Loss	2.04% -40.24	-39.44	-37.51	-35.80	-29.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.23% 0.229	29.67	29.60	28.37	0.7029
Diluted Average Shares	99.23% 0.229	29.67	29.60	28.37	0.7029
Basic Earnings Per Share	0.75% -1.34	-1.33	-1.27	-1.26	-1.10
Diluted Earnings Per Share	0.75% -1.34	-1.33	-1.27	-1.26	-1.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-